| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-06 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |